Welcome to our dedicated page for Hestia Insight news (Ticker: HSTA), a resource for investors and traders seeking the latest updates and insights on Hestia Insight stock.
Hestia Insight Inc. reports company developments tied to AI-enabled capital markets advisory, corporate disclosure technology, and consulting services for emerging growth companies. Recurring announcements cover the Impact-O AI platform, automated compliance screening, news drafting, optional distribution services, and marketing programs for business plans, pitch decks, investor outreach, and capital-raising materials.
Company news has also covered healthcare and biotechnology advisory activity, corporate advisory agreements, strategic relationship discussions, and governance additions. The announcements reflect Hestia Insight’s movement from a healthcare and biotech advisory focus toward AI-supported capital markets services for smaller public and growth-oriented companies.
Hestia Insight (NYSE:HSTA) launched Impact-O on April 29, 2026, an AI suite for drafting news releases and automated compliance screening. The introductory price is $179 per release, delivering two AI-generated draft variations plus an integrated compliance checker and an optional paid distribution service.
The platform targets faster filings, lower legal expense, and access to premium media and financial distribution channels with pricing available upon request.
Hestia Insight Inc. (OTCQB: HSTA) has announced a strategic shift towards capital markets advisory with a focus on integrating artificial intelligence (AI) into its services. The company aims to simplify U.S. capital markets complexities for emerging growth companies by offering AI-driven solutions to enhance efficiency, reduce costs, and improve compliance.
Hestia is phasing out non-core operations to concentrate on supporting emerging companies in the U.S. and Asia through AI-enhanced advisory services. The company has partnered with Edward Boyle, an AI expert, to lead this initiative. Hestia's new focus includes creating high-quality investor presentations and investment documents, particularly for Asian markets where demand is rising.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Hestia Insight (OTCQB: HSTA) has appointed Dr. T.Z. (Ted) Chaung to its advisory board, aiming to enhance growth in healthcare and biotech sectors. Dr. Chaung brings extensive experience in healthcare startups and drug development, previously holding key positions at major pharmaceutical companies such as Merck and Bristol-Myers Squibb. Hestia Insight focuses on strategic acquisitions and developing novel healthcare technologies. This addition is expected to leverage Dr. Chaung's expertise for the company's advancement.
Hestia Insight Inc. (OTCQB: HSTA) has partnered with ChargerGoGo, a major portable phone charging network, to enhance its vending services. Hestia Vending will introduce ChargerGoGo's smartphone charging stations in high-traffic areas, benefiting users with an innovative battery rental system. This move targets the densely populated New York City and Long Island markets, expanding Hestia's footprint. The partnership aims to capitalize on the growing demand for mobile charging solutions in the U.S., leveraging ChargerGoGo's proven success in Asia.
Hestia Insight Inc. (HSTA) has entered a strategic partnership with ChargerGoGo, which operates a substantial portable phone charging network in the U.S. This collaboration aims to introduce smart phone charging station kiosks in high-traffic areas starting in New York City and Long Island. Hestia’s subsidiary, Hestia Health, is also promoting HealthyYOU E-vending machines. The partnership leverages ChargerGoGo's existing presence with over 500 locations in Las Vegas and potential nationwide expansion, aligning with increasing smartphone dependence and convenience needs.